What is up with the stem cell company, Precision StemCell, these days? I can’t imagine they are exactly celebrating after having been reported to the FDA. They also have apparently moved operations from the US to Colombia at some point recently. What’s the deal here? First, a little background is helpful. In 2012, University of […]
Leigh Turner Reports Company Precision StemCell To FDA Read More »
I’ve been fortunate to interview some of the greats in the stem cell field for this blog and host debates between key players. Please note that just because I have interviewed folks does not mean I agree with them or that they agree with me. The point is to establish dialogue on key issues. As
Interviews with leaders and top players in the stem cell field Read More »
Below are links to specific court documents and filings in stem cell-related legal proceedings. (I’ve also placed in parentheses links to my posts/analysis on these). Enjoy, especially you lawyers and investors. It’s a work in progress so expect more cases and documents to appear. In fact, if you have suggested additions please add them (plus
Your stem cell legal documents hub Read More »
It has been a tough year for Korean stem cell biotech RNL Bio in my opinion. It is involved in litigation with former patients and its former partner, Celltex. It is also reportedly under investigation by the Korean Government for alleged stem cell smuggling. The stock of this publicly-traded company has also been battered. On
Tough times at stem cell company RNL Bio Read More »
The Korean-based stem cell biotech, RNL Bio, which also does business in the U.S. as RNL Bio and Human Biostar Inc, reportedly (seems to be a press release, PR) has filed an investigational new drug (IND) application with the Korean FDA (KFDA). The purpose of the application is to test the efficacy of autologous adult stem cells
One of the most important elements of science is critical reading of papers. Most of us come into science as undergrads feeling somewhat naive about what we read in papers. Our default tendency is to believe most or all that we read as “true”. As we get more experienced, we realize that in fact if
Critically reading science papers: response to patient on MS stem cell literature Read More »
A big issue in the stem cell field is that firms increasingly are doing business in multiple countries. Associated with the increasingly international nature of the stem cell for-profit industry are emerging legal and ethical issues related to the transport of stem cell-based biological drugs across international borders. Think you can just FedEx human stem
The Knoepfler Lab 2012 Stem Cell Person of the Year is Roman Reed. Congratulations, Roman Reed! Roman made a tremendous difference in 2012 in many ways. One of the most notable was catalyzing the TJ Atchison Spinal Cord Injury Research Act in Alabama, which provides $400,000/year in funding for research. Of course, TJ and many
Stem Cell Person of the Year 2012: Roman Reed Read More »
RNL Bio had a challenging year in 2012 in my opinion. It was sued in U.S. court for stem cell fraud by Korean national patients living in the U.S. It had a legal tussle, still ongoing, with former partner Celltex over custody of Celltex’s banked patient stem cells. Well, it seems to me that 2013
RNL Bio charges for alleged stem cell smuggling raise larger questions Read More »
In previous years I’ve done yearly predictions for the coming year’s events in the stem cell world (see predictions for 2011 and 2012 predictions). I did pretty well in my predicting stem cell events for this year (see analysis here) scoring a respectable 70%. Isn’t that a C-?,you might ask. No, when it comes to
My stem cell predictions for 2013 Read More »